Sartorius (SARTF) Stock Price, News & Analysis

Company Overview

Sartorius is a life science technology company headquartered in Göttingen, Germany. Founded in 1870 by Florenz Sartorius, the company develops equipment, consumables and services used by biopharmaceutical manufacturers, research laboratories and other organizations in the life sciences industry.

Its Bioprocess Solutions division supplies technologies for the development and production of biologic medicines, including filtration systems, single-use bags and assemblies, bioreactors, process monitoring instruments and related services. These products support processes such as cell culture, purification and the manufacture of vaccines, antibodies and other advanced therapies.

Through its Lab Products and Services activities, Sartorius provides laboratory instruments, balances, laboratory water systems, pipetting products, consumables and other tools used in research and quality-control workflows. The company serves customers internationally through operations, sales organizations and distribution networks across Europe, the Americas and Asia-Pacific.

Key Stats

• Today's Range: $243.86 to $243.86
• 50-Day Range: $212.80 to $243.86
• 52-Week Range: $181.58 to $243.86
• Volume: N/A
• Average Volume: 223 shs
• Market Capitalization: $8.35 billion
• P/E Ratio: 113.42
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 10/16/2025
• Today: 10/01/2026
• Next Earnings (Estimated): 10/22/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:SARTF
• Previous Symbol: NASDAQ:SARTF
• CIK: N/A
• Web: www.sartorius.com
• Phone: 495513080
• Fax: 49-55-1308-3289
• Employees: 13,528
• Year Founded: 1870

Profitability

• EPS (Trailing Twelve Months): $2.15
• Trailing P/E Ratio: 113.42
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $90.90 million
• Net Margins: 3.82%
• Pretax Margin: 8.16%
• Return on Equity: 8.19%
• Return on Assets: 3.15%

Debt

• Debt-to-Equity Ratio: 0.89
• Current Ratio: 0.95
• Quick Ratio: 0.49

Sales & Book Value

• Annual Sales: $3.66 billion
• Price / Sales: 2.28
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 34,230,000
• Free Float: N/A
• Market Cap: $8.35 billion
• Optionable: Not Optionable
• Beta: 0.98